Seidel-Dugan Cynthia 4
4 · Werewolf Therapeutics, Inc. · Filed May 4, 2021
Insider Transaction Report
Form 4
Seidel-Dugan Cynthia
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-30+57,908→ 57,908 totalExercise: $16.00Exp: 2031-04-29→ Common Stock (57,908 underlying) - Award
Stock Option (right to buy)
2020-12-08+99,163→ 99,163 totalExercise: $4.77Exp: 2030-12-07→ Common Stock (99,163 underlying)
Footnotes (2)
- [F1]The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
- [F2]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.